Biomeva: First GMPCompliant Batch of a Biologic Drug Substance from a Moss Expression System Produced for Clinical Use

greenovation Biotech GmbH and BIOMEVA GmbH announced today the successful production of the world's first GMP Good Manufacturing Practicecompliant batch of drug substance manufactured in moss for clinical use. The drug substance greenovation's pilot candid...